diabetes

An excerpt of an op-ed by Robert I. Field, PhD, JD, MPH, professor of the Earle Mack School of Law & Drexel School of Public Health published in Philly.com . Robert I. Field, PhD, JD, MPH What do we get when Congress cuts federal spending across-the-board? Does it bring lower taxes, smaller deficits, and less bureaucracy? How about worse health care, less medical innovation, and lost lives? The budget sequester that Congress enacted in 2011 began to take effect this year with spending cuts for most federal programs. So far, the majority of Americans have seen little change. Some may even applaud the idea of forcing the federal government to make due with less. But the sequester is about...
The United Health Foundation recently released their first-ever comprehensive report on the health of America’€™s senior population. According to a statement from the authors Reed Tuckson, MD and Rhonda Randall, DO , ’€œThe report provides a comprehensive analysis of senior population health rankings on both national and state levels, and it comes at a critical time. Americans are living longer but sicker lives, and America’€™s senior population is poised to grow 53 percent between 2015 and 2030.’€ This fascinating report ranks each state by the incidence of several factors, including obesity, physical inactivity, low-care nursing, and food insecurity. The United Health Foundation, a...
Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research ALEXANDRIA, Va. – June 12, 2013 – More than two-thirds (72%) of Americans say it’s likely they would participate in a clinical trial if recommended by their doctor, but only 22% say a doctor or other health care professional has ever talked to them about medical research, according to a new national public opinion poll commissioned by Research!America. A wide majority (80%) say they have heard of a clinical trial – more than half (53%) through the Internet and only 24% from a doctor or other health care provider. Only 16% of those polled say they or someone in their family have ever...
Thousands of scientists, patients and research advocates gathered on the grounds of the Carnegie Library in Washington, DC, on April 8 to unite behind a call for increased funding for medical research. The Rally for Medical Research was organized by the American Association for Cancer Research in conjunction with their annual meeting and was supported by more than 200 partnering organizations ’€” including Research!America. The program featured statements from patients and their families, scientists, policy makers, and research advocates. Cokie Roberts of ABC News and NPR, cancer survivor and research advocate, was the master of ceremonies. Survivors of heart disease, stroke, HIV, Type 1...
On March 24, World Tuberculosis Day , the Lancet published a series of papers on the need to combat drug-resistant tuberculosis. Cases of drug-resistant TB are on the rise, posing a growing threat to the health of populations in all parts of the world. The series consists of six papers written by international experts in the tuberculosis field, including Professor Alimuddin Zumla, Director of the Centre for Infectious Diseases at the University College London Medical School and Dr. Marco Schito at the National Institute of Allergy and Infectious Diseases. Some papers focus on TB diagnostics, highlighting advances such as the Xpert MTB/RIF test as well as the dire need for new affordable and...
Throughout March, patient and research advocacy groups are observing Autoimmune Awareness Month . There are an estimated 23.5 million Americans suffering from one of nearly 100 autoimmune diseases. Some autoimmune diseases are rare but more common autoimmune disorders include Type 1 diabetes, Crohn’€™s disease and lupus. Autoimmune disease results from the body’€™s natural defense system attacking healthy cells. The target of this attack can be a specific organ, such as insulin-producing cells in the pancreas in Type 1 diabetes, or it can be more widespread throughout the body, as is the case for patients living with lupus or rheumatoid arthritis. Autoimmune patients take medication to not...
January 9, 2013 The U.S. Supreme Court’s dismissal of Sherley v. Sebelius , a case intended to block federal funding for scientists conducting embryonic stem cell research, is a victory for patients and the research community. This key decision will allow the continuation of federal funding from the National Institutes of Health, providing essential support for scientists to conduct lifesaving research. Embryonic stem cells, which can repair or replace damaged tissue and organs, have advanced research aimed at finding cures and therapies to treat a wide variety of diseases and disorders including vision impairment, spinal cord injuries, and multiple sclerosis. Clinical trials have also...
Dear Research Advocate, This week’€™s Nobel Prize announcements are a fine reminder of how government-supported research plays a critical role in expanding our knowledge, leading not only to worldwide recognition but taking us closer to understanding and curing disease. The winners of the prize for chemistry, Dr. Robert Lefkowitz, Howard Hughes Medical Research investigator and professor at Duke University Medical Center, and Dr. Brian Kobilka of Stanford University School of Medicine both received grants from the National Institutes of Health, as did one of the physiology and medicine awardees, Dr. Shinya Yamanaka. They are among the many Nobel laureates whose important work throughout the...
On October 11 th , World Sight Day , the World Health Organization will raise awareness about visual impairment around the world, as well as their Vision 2020 initiative aimed at eliminating avoidable blindness by 2020. WHO estimates that 285 million people worldwide are visually impaired and about 39 million of those individuals are permanently blind. However, up to 80% of these cases are due to preventable causes like cataracts, glaucoma, diabetes, trachoma and onchocerciasis. The last two causes on that list may not sound familiar ’€“ trachoma and onchocerciasis are two types of neglected tropical diseases (NTDs), diseases that have historically received little attention despite...
Dear Research Advocate, As you know, the Republican Party Platform was unveiled Tuesday during the convention in Tampa. There are direct references to medical and health research and other statements that ’€” if not explicit ’€” definitely imply the need for such research. We can draw from both to enhance our advocacy efforts. The following exemplifies the direct and indirect nature of the platform’€™s embrace of medical and health research: ’€œWe support federal investment in health care delivery systems and solutions creating innovative means to provide greater, more cost-effective access to high quality health care. We also support federal investment in basic and applied biomedical...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient